Vivaldi Capital Management LP Abb Vie Inc. Transaction History

Vivaldi Capital Management LP

$341 Million
Q1 2024

A detailed history of Vivaldi Capital Management LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Vivaldi Capital Management LP holds 7,885 shares of ABBV stock, worth $1.29 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

7,885

Previous 9,761 19.22%

Holding current value

$1.29 Million

Previous $1.51 Million 5.09%

% of portfolio

0.42%

Previous 0.45%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $299,822 - $341,619	-1,876 Reduced 19.22%	7,885 $1.44 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $92,467 - $104,139	672 Added 7.39%	9,761 $1.51 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $27,385 - $31,703	205 Added 2.31%	9,089 $1.35 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $28,489 - $35,453	215 Added 2.48%	8,884 $1.2 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $212,142 - $244,314	-1,467 Reduced 14.47%	8,669 $1.38 Million

Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $28,491 - $34,169	206 Added 2.07%	10,136 $1.64 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $1,744 - $2,001	-13 Reduced 0.13%	9,930 $1.38 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $71,149 - $90,454	-517 Reduced 4.94%	9,943 $1.52 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $61,238 - $75,980	464 Added 4.64%	10,460 $1.61 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $2,148 - $2,718	20 Added 0.2%	9,996 $1.35 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $8,416 - $9,376	-80 Reduced 0.8%	9,976 $1.16 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $77,338 - $85,140	-756 Reduced 6.99%	10,056 $1.17 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $4,748 - $6,411	-59 Reduced 0.54%	10,812 $1.16 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $18,556 - $21,779	-216 Reduced 1.95%	10,871 $1.08 Million
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $328,624 - $439,748	-4,479 Reduced 28.77%	11,087 $1.06 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $26,574 - $40,289	412 Added 2.72%	15,566 $1.19 Million
Q4 2019 Feb 11, 2020	SELL	$72.13 - $90.25 $15,868 - $19,855	-220 Reduced 1.43%	15,154 $1.34 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $36,465 - $43,841	-579 Reduced 3.63%	15,374 $1.16 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $74,898 - $95,737	1,140 Added 7.7%	15,953 $1.16 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $584,489 - $687,915	7,577 Added 104.71%	14,813 $1.19 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $563,322 - $694,728	7,236 New	7,236 $667,000

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $290B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivaldi Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Vivaldi Capital Management LP with notifications on news.

Account

Vivaldi Capital Management LP Abb Vie Inc. Transaction History